Tetrasilver Tetroxide: A Sixth source Capture (AntelmanTSTO Variant)

This capture is the sixth TSTO-related record ingested into Bench from the source archive corpus. It reproduces the AntelmanTSTO page — a combined sales page and patent reference dossier for tetrasilver tetroxide (TSTO, Ag₄O₄) attributed to the chemist and inventor Marvin S. Antelman. The page sits in the archive's tetrasilver-tetroxide dossier folder and presents the compound as a commercial product line alongside citations to Antelman's patents.

Because the wiki already holds five earlier TSTO captures plus a dedicated claims-vs-evidence comparison, this page is best read as a variant record rather than a new subject. It restates the same core claims in the same commercial-plus-patent framing and adds no new mechanism, dataset, or quantitative result. Its value to the knowledge base is provenance: it documents that the AntelmanTSTO page was captured again, in this form, at this location.

What the page is

The capture is a product-and-patent dossier rather than a technical paper. Its structure is characteristic of the archive's commercial pages:

• A product presentation of TSTO formulations, with product imagery and branding.
• References to Antelman's patents as the supporting documentation for the claims made on the page.
• Application claims for antimicrobial and water-treatment uses.

The page does not report an experimental protocol, a measurement series, or an independent test. There is no tabulated efficacy data, no dose–response information, and no third-party replication. The evidentiary weight therefore rests entirely on the patent references and on the page's own assertions.

Claims as stated

The claims reproduced in this capture match those in the earlier TSTO records. They are source assertions, attributed to Antelman and the product line, and are not independently verified by Bench:

1. Identity. TSTO is a mixed-valence silver oxide with the formula Ag₄O₄, combining silver in the Ag(I) and Ag(III) oxidation states within a single crystal lattice. See Tetrasilver Tetroxide (Ag₄O₄) and Silver(I,III) Oxide.
2. Mechanism. The compound is described as an "electron jumping compound" or "molecular battery," in which electrons are said to move between silver valence states and thereby sustain a redox effect. This is the Electron Jumping Compound / Molecular Battery Claim, grounded in the Mixed-Valence Silver Oxide picture of the lattice.
3. Antimicrobial action. Disinfection and antimicrobial uses are claimed on the basis of silver's Antimicrobial Silver and the Oligodynamic Effect — the toxicity of silver ions to microorganisms.
4. Water treatment. Practical application is claimed for Water Disinfection by Silver, treating water with the silver species.
5. Evidence base. Patents are offered as the primary support for the above. The methodological caveat in Patent as Evidence applies directly: a patent documents a claimed invention and its enablement, not demonstrated efficacy.

The synthesis route for the compound is referenced in the wider dossier but is not resolved by this capture; see Tetrasilver Tetroxide Preparation (Unresolved in This Capture).

Technical details and methods

This capture supplies no preparative procedure, no characterization data (no diffraction, spectroscopy, or elemental analysis), and no assay conditions. The only structured content is the set of image assets the page references, which include product imagery and a site logo. One of those assets, TetraSilver TetrOxide Information: The Lattice Diagram and the Two-Part Mechanism Claim, is already recorded in the wiki; the remaining images are product and branding graphics rather than diagrams of a mechanism or apparatus.

Readers seeking the technical substance of the TSTO claim should consult the earlier, more complete captures in the cluster, which carry the same claims with the same absence of primary data.

Observations and evidence

Nothing in this capture constitutes new evidence. It repeats the sales-and-patent pattern already documented:

• The page is simultaneously promotional and documentary — it markets a product while citing patents as proof. That tension is the defining feature of the TSTO dossier as a whole.
• No independent replication, clinical trial, or quantitative antimicrobial result appears here.
• The claims are internally consistent with the five prior TSTO captures, so this record neither contradicts nor extends the existing picture.

The appropriate comparison page remains Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Bounded Evidence, which sets the dossier's assertions against the absence of supporting test data. This sixth capture adds a data point to the "no new evidence" column of that comparison.

Limitations and unresolved questions

• Capture completeness. The page was captured with a nonzero probability of capture problems, and the image list mixes product graphics with a site logo — consistent with a commercial page that may not have been captured in full. The body content available here is thin relative to the earlier TSTO records.
• No primary data. As with the other captures, the absence of any measurement, protocol, or independent test means the efficacy claims cannot be assessed from this source.
• Redundancy. This record largely duplicates existing TSTO source pages. Whether the wiki should keep one page per capture or consolidate variants into a single page with a variant log is an open editorial question.
• Unresolved preparation. The synthesis of Ag₄O₄ remains unresolved in this capture, as in the preparation-page record.

Related work

• Tetrasilver Tetroxide (Ag₄O₄) — the compound at the center of the dossier.
• Marvin S. Antelman — the named author and patentee.
• TSTO Product Line (Tetrasilver Tetroxide Formulations) — the commercial formulations presented on the page.
• Electron Jumping Compound / Molecular Battery Claim — the "molecular battery" mechanism claim.
• Mixed-Valence Silver Oxide — the lattice picture underlying the claim.
• Antimicrobial Silver and the Oligodynamic Effect and Water Disinfection by Silver — the application claims.
• Patent as Evidence — the methodological caveat governing how the patent citations should be read.
• Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Bounded Evidence — the standing comparison of TSTO claims against available evidence.
• the source archive — the host archive.